Synergistic cell death induction in breast cancer cell lines by combining ABT-199 and cisplatin irrespective of estrogen receptor and p53 expression.

被引：0
|
作者：
Schaefer, Benjamin [1 ,2 ]
Weller, Sandra [1 ,2 ]
Beigl, Tobias [1 ,2 ]
Boepple, Kathrin [1 ,2 ]
Hoppe, Reiner [1 ,2 ]
Schulze-Osthoff, Klaus [2 ]
Kopp, Hans-Georg [3 ,4 ]
Aulitzky, Walter E. [3 ]
Essmann, Frank [1 ,2 ]
机构：
[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany
[2] Univ Tubingen, Stuttgart, Germany
[3] Robert Bosch Krankenhaus, Stuttgart, Germany
[4] Robert Bosch Ctr Tumor Dis, Stuttgart, Germany
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1946
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Depletion of CTCF in Breast Cancer Cells Selectively Induces Cancer Cell Death via p53
    Lee, Ji-Yeon
    Mustafa, Muhammad
    Kim, Clara Yuri
    Kim, Myoung Hee
    JOURNAL OF CANCER, 2017, 8 (11): : 2124 - 2131
  • [42] Estrogen induces apoptosis in a breast cancer cell model resistant to estrogen withdrawal through induction of p53 and causes complete tumor regression in vivo
    Lewis, JS
    Meeke, K
    Osipo, C
    Chandel, NS
    Jordan, VC
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S29 - S30
  • [43] Induction of tubulin by Docetaxel is associated with p53 status in human non small cell lung cancer cell lines
    Chang, JT
    Chang, GC
    Ko, JL
    Liao, HY
    Liu, HJ
    Chen, CC
    Su, JM
    Lee, H
    Sheu, GT
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (02) : 317 - 325
  • [44] Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion
    Mehta, S. A.
    Christopherson, K. W.
    Bhat-Nakshatri, P.
    Goulet, R. J., Jr.
    Broxmeyer, He
    Kopelovich, L.
    Nakshatri, H.
    ONCOGENE, 2007, 26 (23) : 3329 - 3337
  • [45] Inhibition of SIRT1/p53 pathway by miR-211 and induction of cell death in breast cancer cells
    Nourbakhsh, M.
    Yarahmadi, S.
    Abdolvahabi, Z.
    Hesari, Z.
    Tavakoli-Yaraki, M.
    Yousefi, Z.
    Seiri, P.
    FEBS OPEN BIO, 2019, 9 : 244 - 245
  • [46] Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion
    S A Mehta
    K W Christopherson
    P Bhat-Nakshatri
    R J Goulet
    H E Broxmeyer
    L Kopelovich
    H Nakshatri
    Oncogene, 2007, 26 : 3329 - 3337
  • [47] Comparative Immunofluorescent Analysis of Estrogen Receptor Beta Expression in Ovarian and Breast Cancer Cell Lines
    Bogush, T. A.
    Basharina, A. A.
    Burova, O. S.
    Bogush, E. A.
    Kirsanov, V. Yu.
    Scherbakov, A. M.
    Syuvatkin, V. A.
    Ryabinina, O. M.
    Baryshnikova, M. A.
    Kosorukov, V. S.
    MOSCOW UNIVERSITY CHEMISTRY BULLETIN, 2020, 75 (05) : 274 - 279
  • [48] Simultaneous expression of nitric oxide synthase and estrogen receptor in human breast cancer cell lines
    Zeillinger, R
    Tantscher, E
    Schneeberger, C
    Tschugguel, W
    Eder, S
    Sliutz, G
    Huber, JC
    BREAST CANCER RESEARCH AND TREATMENT, 1996, 40 (02) : 205 - 207
  • [49] Estrogen receptor β agonists affect growth and gene expression of human breast cancer cell lines
    Lattrich, Claus
    Stegerer, Anette
    Haering, Julia
    Schueler, Susanne
    Ortmann, Olaf
    Treeck, Oliver
    STEROIDS, 2013, 78 (02) : 195 - 202
  • [50] Comparative Immunofluorescent Analysis of Estrogen Receptor Beta Expression in Ovarian and Breast Cancer Cell Lines
    T. A. Bogush
    A. A. Basharina
    O. S. Burova
    E. A. Bogush
    V. Yu. Kirsanov
    A. M. Scherbakov
    V. A. Syuvatkin
    O. M. Ryabinina
    M. A. Baryshnikova
    V. S. Kosorukov
    Moscow University Chemistry Bulletin, 2020, 75 : 274 - 279
12345